BOI.PA - Boiron SA

Paris - Paris Delayed price. Currency in EUR

Boiron SA

2, avenue de l'Ouest Lyonnais
Messimy 69510
33 4 78 45 61 00

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees3,567

Key executives

NameTitlePayExercisedYear born
Ms. Valérie Lorentz-PoinsotGen. Mang. & Exec. Director821.58kN/A1969
Mr. Jean-Christophe BayssatDeputy GM, Chief Pharmacist & Director of Pharmaceutical Devel.1.18MN/A1963
Mr. Bruno GrangeInternational Controller & Director16.22kN/A1953
Eric LambertAdmin. & Financial DirectorN/AN/AN/A
David SoussanGroup Marketing DirectorN/AN/AN/A
Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines; and proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum for the treatment of influenza symptoms; Stodal and Stodaline to treat coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for nursing babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's branded homeopathic medicines comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat ocular discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. It offers its products through distribution centers, pharmacy chains, wholesalers, supermarkets, drugstores, and health food stores. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Corporate governance

Boiron SA’s ISS governance QualityScore as of 6 December 2019 is 10. The pillar scores are Audit: 5; Board: 9; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more